Health News E Clips
An electronic healthcare news link service provided by the Utah Hospital Association
To unsubscribe, contact firstname.lastname@example.org
www.utahhospitals.org Twitter: @utahhospitals
Tuesday, October 2, 2012
Utah Healthcare Headlines
Advocates for Utah’s poor want expanded access to Medicaid (Salt Lake Tribune, September 29,
2012) With new figures showing that more Utahns are living in poverty, advocates gathered Saturday
to discuss policies to help those growing ranks, including expanding Medicaid and maintaining low-
cost mass transit.
Court: Utah Medicaid erred by denying speech-aid devices to adults (Salt Lake Tribune, October 1,
2012) Utah Medicaid officials abused their discretion by denying electronic speech-aid devices to
disabled recipients based on their age, the Utah Court of Appeals ruled Thursday.
Employee health clinics on the rise (Provo Daily Herald, September 30, 2012) With the costs of health care
skyrocketing and the uncertainty of the changing health care system, many employers are wondering where to
go next. Several large companies in Utah County may have found the answer.
Cancer expo, survivor conference give patients tools, hope (Deseret News, September 29, 2012)
Dov Siporin doesn't know if he'll make it to the end of his kids' school year — he actually doesn't
know if he'll live through today.
National Healthcare Headlines
For hospitals, health reform starts today (Washington Post, October 2, 2012) The start of October
means, for most Americans, the onset of chilly weather and a chance to start thinking up a new
Halloween costume. For budget wonks, it signifies the start of a new fiscal year.
Hospitals to be fined over readmitted patients (Salt Lake Tribune, October 1, 2012) If you or
an elderly relative have been hospitalized recently and noticed extra attention when the time
came to be discharged, there’s more to it than good customer service.
Many states not prepared for health-care law (Washington Post, October 2, 2012) More than three
dozen states could be unprepared or unwilling to set up the insurance marketplaces called for under
the 2010 health-care law, leaving at least part of the task up to the federal government, according to
a new report.
Administration Advises States to Expand Medicaid or Risk Losing Federal Money (New York Times,
October 2, 2012) The Obama administration is putting pressure on states to expand Medicaid,
telling them they may lose federal money if they delay.
The Conservative Case for Obamacare (Opinion, New York Times, September 29, 2012) IF Mitt
Romney’s pivots on President’s Obama’s health care reform act have accelerated to a blur — from
repealing on Day 1, to preserving this or that piece, to punting the decision to the states — it is for an
odd reason buried beneath two and a half years of Republican political condemnations: the
architecture of the Affordable Care Act is based on conservative, not liberal, ideas about individual
responsibility and the power of market forces.
When Doctors Stop Taking Insurance (New York Times, October 2, 2012) Private health insurance
used to be the ticket to a doctor’s appointment. But that’s no longer the case in some affluent
metropolitan enclaves, where many physicians no longer accept insurance and require upfront
payment from patients — cash, checks and credit cards accepted.
Doctor Visits Dropping, New Census Figures Show (New York Times, October 1, 2012) Americans of
working age are going to the doctor less frequently than they were 10 years ago, according to a new
report by the Census Bureau.
Access to Doctors' Notes Aids Patients' Treatment (Wall Street Journal, October 1, 2012) Patients
who have access to doctor's notes in their medical records are more likely to understand their health
issues, recall what the doctor told them and take their medications as prescribed, according to a
study published Monday.
An Unfinished Campaign Against Polio (Editorial, New York Times, September 28, 2012) Leaders of
the global fight to eradicate polio vowed at the United Nations on Thursday to step up their efforts to
eliminate the virus from the three countries where the disease still has a foothold — Afghanistan,
Pakistan and Nigeria.
Health officials push for more people to get flu shot (USA Today, September 28, 2012) There are
plenty of flu shots available this year, and health officials urged Americans on Thursday to roll up
their sleeves and get vaccinated -- if not for their own sakes, then for the health of their
Report Sees Less Impact in New Autism Definition (New York Times, October 2, 2012) Proposed
changes to the official diagnosis of autism will not reduce the proportion of children found to have it
as steeply as many have feared, scientists reported on Tuesday, in an analysis that contradicts
several previous studies.
Overnight dementia care gives caregivers some rest (USA Today, October 1, 2012) Just after 10
p.m., when most people their age are going to sleep, a group of elderly folks suffering from dementia
are just getting started, dancing and shaking tambourines and maracas in a raucous version of La
New Strategy May Boost Fertility Clinic Success Rate (Wall Street Journal, October 2, 2012) Fewer
than half of women seeking help from a fertility clinic succeed at having a baby after just one
treatment. Now, some researchers believe they have come upon a way to improve those odds.
FDA warns of risks of online pharmacies (USA Today, September 28, 2012) The Food and Drug
Administration is warning U.S. consumers that the vast majority of Internet pharmacies are
fraudulent and likely are selling counterfeit drugs that could harm them.
Study Finds HPV Vaccine Gardasil Safe (Wall Street Journal, October 2, 2012) A new study of Merck
& Co.'s Gardasil cervical-cancer vaccine showed it was associated with fainting on the day of
inoculation and skin infections two weeks afterward, but no link with more serious health problems
Roche Develops Cure for European Drug Makers (Wall Street Journal, October 1, 2012) Switzerland's
Roche Holding AG may have struck upon a strategy to deal with a problem that is making life difficult
for other big pharmaceutical companies in Europe: the loss of patent protection.